Statistical process control analysis for patient-specific IMRT and VMAT QA
Open Access
- 7 December 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Radiation Research
- Vol. 54 (3), 546-552
- https://doi.org/10.1093/jrr/rrs112
Abstract
This work applied statistical process control to establish the control limits of the % gamma pass of patient-specific intensity modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT) quality assurance (QA), and to evaluate the efficiency of the QA process by using the process capability index (Cpml). A total of 278 IMRT QA plans in nasopharyngeal carcinoma were measured with MapCHECK, while 159 VMAT QA plans were undertaken with ArcCHECK. Six megavolts with nine fields were used for the IMRT plan and 2.5 arcs were used to generate the VMAT plans. The gamma (3%/3 mm) criteria were used to evaluate the QA plans. The % gamma passes were plotted on a control chart. The first 50 data points were employed to calculate the control limits. The Cpml was calculated to evaluate the capability of the IMRT/VMAT QA process. The results showed higher systematic errors in IMRT QA than VMAT QA due to the more complicated setup used in IMRT QA. The variation of random errors was also larger in IMRT QA than VMAT QA because the VMAT plan has more continuity of dose distribution. The average % gamma pass was 93.7% ± 3.7% for IMRT and 96.7% ± 2.2% for VMAT. The Cpml value of IMRT QA was 1.60 and VMAT QA was 1.99, which implied that the VMAT QA process was more accurate than the IMRT QA process. Our lower control limit for % gamma pass of IMRT is 85.0%, while the limit for VMAT is 90%. Both the IMRT and VMAT QA processes are good quality because Cpml values are higher than 1.0.Keywords
This publication has 20 references indexed in Scilit:
- Evaluation of volumetric modulated arc therapy (VMAT) with Oncentra MasterPlan® for the treatment of head and neck cancerRadiation Oncology, 2010
- Early clinical experience with volumetric modulated arc therapy in head and neck cancer patientsRadiation Oncology, 2010
- A comprehensive analysis of the IMRT dose delivery process using statistical process control (SPC)Medical Physics, 2009
- Moving from IMRT QA measurements toward independent computer calculations using control chartsRadiotherapy and Oncology, 2008
- Statistical process control for IMRT dosimetric verificationMedical Physics, 2008
- An analysis of tolerance levels in IMRT quality assurance proceduresMedical Physics, 2008
- Agreement criteria between expected and measured field fluences in IMRT of head and neck cancer: The importance and use of the γ histograms statistical analysisRadiotherapy and Oncology, 2007
- Radiation‐induced xerostomia in patients with head and neck cancerCancer, 2006
- Interpretation and evaluation of the γ index and the γ index angle for the verification of IMRT hybrid plansPhysics in Medicine & Biology, 2005
- SPC—GENERALIZATION OF CAPABILITY INDEXCpm: CASE OF UNILATERAL TOLERANCESQuality Engineering, 1997